This is a testimony that GR-CIS is one among few Regulatory Service provider in the country who not only believes in QUALITY but excel in the same. With no findings and no observations this was the fourth audit in a…
New Recommendations for speeding approvals of Global Clinical Trials
In 34th Apex Committee which was held on 02 June 2017, there were recommendation to remove three tier review of the studies in India. Here are the highlights The Committee was apprised that the system of examination of proposals in…
